US FDA Eyes Project Orbis-Type Approach For Cell And Gene Therapies

Globe puzzle
CBER wants to take a more global view of the regulation of cell and gene therapies for very rare diseases. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies